1. Home
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
Middle East & Africa Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Disease Indication, Procedure, and End User

Middle East & Africa Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Disease Indication, Procedure, and End User

  • November 2022
  • 174 pages
  • ID: 6368939
  • Format: PDF
  • The Insight Partners

Summary

Table of Contents

Search Inside

The embolotherapy market in the Middle East & Africa is expected to grow from US$ 183.66 million in 2022 to US$ 261.89 million by 2028. It is estimated to grow at a CAGR of 6.1% from 2022 to 2028.

Widening Applications of Embolotherapy to Bolster Embolotherapy Market in Middle East & Africa during 2022–2028

Embolization is performed within the artery (endovascular) through a steerable catheter inserted into the bloodstream and guided to the brain.Further, post-traumatic bleeding embolization is performed to stop bleeding caused by traumatic injuries.

The method uses materials to block the affected vessel and stops blood flow.According to a Netcare hospital article, traumatic brain injury (TBI) is one of the leading causes of disability in South Africa, and 89,000 new cases of TBI are reported every year in the country.

Thus, the rising adoption of embolization in various applications further increases the demand for embolization agents and supportive devices.Therefore, the growing applications of embolotherapy devices are expected to boost the growth of the embolotherapy market.

Also, the increasing implementation of embolotherapy in the treatment of endovascular disease, traumatic injuries, cerebrovascular malformation, venous malformation, arteriovenous malformation, and pediatric vascular conditions is expected to offer lucrative opportunities for the market growth in the coming years.

Market Overview

The embolotherapy market in the Middle East & Africa is segmented into Saudi Arabia, the UAE, South Africa, and the rest of Middle East & Africa.In the current market scenario, Middle East is experiencing an increasing incidence of chronic diseases, such as strokes, neurological disorders, and cancer; rise in geriatric population; and adaption of unhealthy lifestyles.

Moreover, acceptance and installations of modern technologies are projected to drive the market growth in this region.The high incidence of chronic diseases, the rise in aging population, and improvements in the treatment procedures of various chronic conditions are among the key factors propelling the market growth in Saudi Arabia.

CVD is the most significant cause of premature death in Saudi Arabia.It accounts for ~37% of deaths in the country.

As per a study, the prevalence rates of chronic diseases in Saudi Arabia has surged in the past few years, accounting for ~60 and ~73% of the total premature deaths in 2016 and 2020, respectively. Hypertension is the most common chronic disease, with prevalence rates of 26%. In addition, in the country, the incidence of uterine fibroids (UFs) at reproductive age is 21.2% in 2018 and poses a major burden on fertile Saudi women. Uterine fibroid embolization, a safe, effective, and minimally invasive procedure is becoming an important gynecological and interventional radiological procedure to treat UF. King Fahd Hospital – Al-Hofouf has successfully treated several benign uterine fibroids cases using uterine fibroid embolization, as per Al-Ahsa Health Affairs. This treatment uses a form of real-time x-ray to guide delivery of embolic agents to the uterus and fibroids. The agents block the arteries that provide blood to the fibroids and cause them to shrink and clear up.

Middle East & Africa Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Embolotherapy Market Segmentation

The Middle East & Africa embolotherapy market is segmented into product, disease indication, procedure, end user, and country.
Based on procedure, the market is segmented into embolic agents and support devices.The embolic agents segment registered the largest market share in 2022.

Based on disease indication, the market is categorized into cancer, neurological diseases, urological and nephrological disorders, peripheral vascular diseases, gastrointestinal disorders, and others.The cancer segment held the largest market share in 2022.

Based on procedure, the Middle East & Africa embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization/selective internal radiation therapy, and transarterial chemoembolization (TACE).The transcatheter arterial embolization (TAE) segment held the largest market share in 2022.

Based on end user, the Middle East & Africa embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held the largest market share in 2022. Based on country, the market is segmented into Saudi Arabia, South Africa, the UAE, and the rest of the MEA. China dominated the market share in 2022. Abbott Laboratories; Boston Scientific Corporation; Cook Medical LLC; Johnson & Johnson; Medtronic; Acandis GmbH; Balt USA LLC; Stryker Corporation; Guerbet LLC; and Terumo Corporation are the leading companies operating in the embolotherapy market in the region.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Endoscopic Submucosal Dissection Market by Product, Indication, End User - Global Forecast to 2027

  • $ 4950
  • January 2023
  • 197 pages

The global endoscopic submucosal dissection market is projected to reach USD 483 million by 2027 from USD 347 million in 2022, at a CAGR of 6.9%. Endoscopic submucosal dissection (ESD) is an advanced ...

  • World
  • Healthcare
  • Hospital
  • Industry analysis
  • Cervical Cancer Screening Coverage
  • Health Expenditure

ref:plp2022

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on